Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aramis Tommy unisex toiletries line in test market now.

This article was originally published in The Rose Sheet

Executive Summary

ARAMIS TOMMY TOILETRIES LINE DEBUTING in a test market in Beverly Hills, Calif. The trial run for the newest venture in the company's successful Tommy franchise will span the country with at least 10 test market cities, including New York, San Francisco, Charlotte, N.C., Washington, D.C. and Miami, slated to feature the products in select department store doors. Roll out of the test market will continue through April. Print advertising in local markets will support the line. The Tommy toiletries collection, still under development, includes approximately 30 SKUs of body, hair and skin care products.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel